Olr413 inhibitors are a class of chemical compounds that interact specifically with the olfactory receptor 413 (Olr413), a G protein-coupled receptor (GPCR) predominantly found in olfactory tissues. These inhibitors are designed to bind to the Olr413 receptor, modulating its activity by either preventing or altering the receptor's ability to detect or respond to certain odorant molecules. The molecular interactions between Olr413 inhibitors and the receptor are typically characterized by high specificity and affinity, which are crucial for achieving precise modulation of the receptor's function. This specificity is often achieved through intricate molecular designs that allow these inhibitors to fit snugly within the binding pocket of Olr413, effectively blocking or altering its normal conformation and signaling pathways. The study of Olr413 inhibitors has gained interest in chemical biology due to their potential to reveal insights into the fundamental mechanisms of olfactory perception and the broader roles of GPCRs in sensory processes.
Structurally, Olr413 inhibitors are diverse, ranging from small organic molecules to more complex synthetic compounds. The design and synthesis of these inhibitors often involve extensive computational modeling and structure-activity relationship (SAR) studies to optimize their interaction with the Olr413 receptor. Chemical modifications are typically employed to enhance the stability, bioavailability, and selectivity of these inhibitors, making them valuable tools in studying receptor dynamics. The ability to precisely control Olr413 activity using these inhibitors provides researchers with the means to dissect the receptor's role in olfaction and to explore how modifications in receptor function can influence olfactory signaling pathways. The chemical exploration of Olr413 inhibitors also contributes to a broader understanding of GPCR modulation, potentially influencing future research in receptor biology and sensory systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $73.00 $163.00 | 2 | |
Calcium channel blocker, can indirectly affect GPCR signaling by altering calcium dynamics, potentially impacting Olr413. | ||||||
Bosentan | 147536-97-8 | sc-210957 | 10 mg | $191.00 | 3 | |
Endothelin receptor antagonist, might influence GPCR signaling indirectly through endothelin pathways, impacting Olr413. | ||||||
Clopidogrel | 113665-84-2 | sc-507403 | 1 g | $120.00 | 1 | |
Platelet aggregation inhibitor, could modulate GPCR signaling indirectly through platelet function, impacting Olr413. | ||||||
Eplerenone | 107724-20-9 | sc-203943 sc-203943A | 10 mg 50 mg | $108.00 $612.00 | 4 | |
Aldosterone antagonist, can influence GPCR signaling indirectly through mineralocorticoid pathways, impacting Olr413. | ||||||
Ivabradine hydrochloride | 148849-67-6 | sc-507513 | 10 mg | $120.00 | ||
If channel inhibitor, might modulate GPCR signaling indirectly through cardiac electrophysiological effects, impacting Olr413. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $127.00 | 18 | |
Angiotensin II receptor blocker, could indirectly affect GPCR signaling, potentially impacting Olr413. | ||||||
Prasugrel | 150322-43-3 | sc-391536 | 100 mg | $77.00 | ||
Antiplatelet drug, may affect GPCR signaling indirectly through inhibition of platelet aggregation, impacting Olr413. | ||||||
Rivaroxaban | 366789-02-8 | sc-208311 | 2 mg | $155.00 | 18 | |
Anticoagulant, can modulate GPCR signaling indirectly through coagulation pathway effects, impacting Olr413. | ||||||
Telmisartan | 144701-48-4 | sc-204907 sc-204907A | 50 mg 100 mg | $71.00 $92.00 | 8 | |
Angiotensin II receptor blocker, might indirectly influence GPCR signaling, potentially impacting Olr413. | ||||||
Valsartan | 137862-53-4 | sc-220362 sc-220362A sc-220362B | 10 mg 100 mg 1 g | $39.00 $90.00 $120.00 | 4 | |
Angiotensin II receptor antagonist, could alter GPCR signaling indirectly, potentially impacting Olr413. | ||||||